Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation

Acute-Phase Proteins and Other Systemic Responses to Inflammation

1999 • 6,324 citations

Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis

2001 • 5,900 citations

Bone marrow transplant

1997 • 3,583 citations

Bone marrow transplant

1999 • 2,452 citations

Veno-occlusive Disease of the Liver and Multiorgan Failure after Bone Marrow Transplantation: A Cohort Study of 355 Patients

1993 • 1,173 citations

Total Body Irradiation and Acute Graft-Versus-Host Disease: The Role of Gastrointestinal Damage and Inflammatory Cytokines

1997 • 838 citations

Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6

1990 • 742 citations

Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups

1993 • 684 citations

Cytokine dysregulation and acute graft-versus-host disease

1992 • 617 citations

Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation [see comments]

1990 • 591 citations

Cytokine dysregulation and acute graft-versus-host disease

1992 • 565 citations

The syndrome of hepatic veno-occlusive disease after marrow transplantation

1995 • 475 citations

Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party.

1998 • 344 citations

Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease

2000 • 241 citations

Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease

2000 • 240 citations

IDIOPATHIC PNEUMONIA SYNDROME

1997 • 222 citations

The efficacy and safety of recombinant human activated protein C for the treatment of patients with severe sepsis (vol 28, pg 48, 2000)

2001 • 220 citations

Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F)

1995 • 198 citations

Defibrotide for the treatment of hepatic veno‐occlusive disease: results of the European compassionate‐use study

2000 • 184 citations

Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease

1992 • 176 citations

A humanized non–FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease

2002 • 173 citations

Graft‐versus‐Host Disease in Dog and Man: The Seattle Experience

1985 • 165 citations

Pathogenesis of Acute Graft-Versus-Host Disease: Cytokines and Cellular Effectors

2000 • 164 citations

Plasminogen Activator Inhibitor-1 Confirms the Diagnosis of Hepatic Veno-Occlusive Disease in Patients With Hyperbilirubinemia After Bone Marrow Transplantation

1997 • 143 citations

Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease

1992 • 139 citations

Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFα antibody

2001 • 137 citations

IC14, an Anti-CD14 Antibody, Inhibits Endotoxin-Mediated Symptoms and Inflammatory Responses in Humans

2001 • 129 citations

Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study

2000 • 127 citations

Marrow engraftment and clinical manifestations of capillary leak syndrome.

1996 • 120 citations

The Hemodynamic Effects of Treatment with Interleukin-2 and Lymphokine-Activated Killer Cells

1988 • 118 citations

Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products

1990 • 109 citations

Treatment of steroid-refractory acute graft-versus-host disease with anti-CD147 monoclonal antibody ABX-CBL

2001 • 98 citations

Idiopathic pneumonia after bone marrow transplantation: Cytokine activation and lipopolysaccharide amplification in the bronchoalveolar compartment

1999 • 97 citations

THE RELATIONSHIP OF SERUM IL-6 LEVELS TO ACUTE GRAFT-VERSUS-HOST DISEASE AND HEPATORENAL DISEASE AFTER HUMAN BONE MARROW TRANSPLANTATION

1992 • 92 citations

Naturally occurring anticoagulants and bone marrow transplantation: plasma protein C predicts the development of venocclusive disease of the liver

1993 • 89 citations

Activation of the complement system during immunotherapy with recombinant IL-2. Relation to the development of side effects.

1990 • 87 citations

Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study

1998 • 73 citations

Monitoring of C-reactive protein after allogeneic bone marrow transplantation identifies patients at risk of severe transplant-related complications and mortality

1998 • 49 citations

Predictive markers for hepatic veno-occlusive disease after hematopoietic stem cell transplantation in adults: a prospective single center study

2000 • 48 citations

Serum levels of cytokines after bone marrow transplantation: increased IL‐8 levels during severe veno‐occlusive disease of the liver

1997 • 45 citations

Complement activation in cancer patients undergoing immunotherapy with interleukin-2 (IL-2): binding of complement and C-reactive protein by IL-2-activated lymphocytes

1991 • 43 citations

Pre-emptive therapy of acute graft-versus-host disease: a pilot study with antithymocyte globulin (ATG)

2001 • 41 citations

ASSOCIATION OF GLUCOCORTICOIDS AND CYCLOSPORIN A OR RAPAMYCIN PREVENTS E-SELECTIN AND IL-8 EXPRESSION DURING LPS- AND TNF??-MEDIATED ENDOTHELIAL CELL ACTIVATION1

2000 • 38 citations

N-terminal peptide of type III procollagen: a marker for the development of hepatic veno-occlusive disease after BMT and a basis for determining the timing of prophylactic heparin.

1993 • 37 citations

Does early treatment with high-dose methylprednisolone alter the course of hepatic regimen-related toxicity?

2000 • 34 citations

Serum hyaluronic acid in patients with veno-occlusive disease following bone marrow transplantation

2001 • 26 citations

THE CLINICAL IMPACT OF EARLY GRAM-POSITIVE BACTEREMIA AND THE USE OF VANCOMYCIN AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION

2000 • 18 citations

High plasma levels of tumor necrosis factor-alpha may be predictive of veno-occlusive disease in bone marrow transplantation [letter]

1994 • 17 citations

Monoclonal Antibodies in the Treatment of Steroid‐Resistant Acute Graft‐versus‐Host Disease

1998 • 8 citations